Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight

1 Mar 2021

Abstract excerpt

Metabolic reprogramming is a key hallmark of cancer and shifts cellular metabolism to meet the demands of biomass production necessary for abnormal cell reproduction. One-carbon metabolism (1CM) contributes to many biosynthetic pathways that fuel growth and is comprised of a complex network of enzymes. Methotrexate and 5-fluorouracil were pioneering drugs in this field and are still widely used today as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biochemical and Molecular Research
Share to Cancer, Hypoxia, and Metabolism
Share to Folate and B Vitamins Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33860190
DOI: 10.1021/acsptsci.0c00223

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the SpotlightPMID 33860190Read ↗

More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?Semantic proximity Read ↗

Multifaceted role of serine hydroxymethyltransferase in health and diseaseSemantic proximity Read ↗

MTHFD2 in healthy and cancer cells: Canonical and non-canonical functionsSemantic proximity Read ↗

Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based InhibitorSemantic proximity Read ↗

Identification of three new compounds that directly target human serine hydroxymethyltransferase 2Semantic proximity Read ↗

Mitochondrial one-carbon enzyme MTHFD1L sustains stemness and metastatic progression in breast cancerSemantic proximity Read ↗

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysisSemantic proximity Read ↗

The catalytic activity of serine hydroxymethyltransferase is essential for de novo nuclear dTMP synthesis in lung cancer cells.Semantic proximity Read ↗

Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapySemantic proximity Read ↗

Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductaseSemantic proximity Read ↗

Inhibition Of One-Carbon Metabolism In Ewing Sarcoma Results In Profound And Prolonged Growth Suppression Associated With Purine DepletionSemantic proximity Read ↗

Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and NeurodegenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.